GSD Type 4
Also known as Andersen Disease, Brancher Deficiency
Defect Defective glycogen-branching enzyme activity.
- Congenital neuromuscular form
- Childhood neuromuscular form - both are associated with isolated or predominant muscle involvement ,with the development of myopathy (muscle weakness) or cardiomyopathy at birth or during childhood.
- Perinatal form severe neuromuscular involvement and death.
- Adult Polyglucosan body disease (APBD) – a subset of which have deficient glycogen-
Branching enzyme activity and diffuse CNS and peripheral nervous system dysfunction.
Cause Defect in the gene that encodes for the glycogen-branching enzyme (GBE1) located on the chromosome band 3p12.This specific enzyme increases the number of branch points during glycogen synthesis.
Incidence An uncommon form of GSD accounting approximately 3% of all cases.
Signs & Symptoms
- Classic presentation involves development of hepatospenomegaly and failure to thrive in the first year of life.
- A milder congenital form is associated with hypotonia (weak muscles) and gross motor delay, without affecting the liver and the heart.
- Patients with progressive liver cirrhosis and associated portal hypertension may also present itching, fatigue, Anorexia (loss of appetite), weakness, jaundice (yellowish discoloration of the skin & mucous membranes), nose bleed, and easy bruising.
- May present cardiomyopathy
- Patients with APBD will present muscle weakness, fatigue, gait disturbance, voiding difficulties, peripheral neuropathy and mild cognitive impairment and dementia.
Diagnosis
- Laboratory studies
- Imaging studies ( Ultrasound, CT Scan, MRI, Echocardiography, Proton MR spectroscopy)
- Liver biopsy or biopsy of affected organs
Treatment
- Medical Consults – based on organ affectation.
- Medications – depending on organ involvement
- Dietary – to provide adequate nutrient intake to maintain normal blood sugar levels and improve liver functions.
- Surgical – liver transplant.
Prognosis
- Poor with perinatal-onset (period between birth to five months) form who does not undergo liver transplantation.
- Long-term for those classic GSD type IV who has undergome transplantation depending on the extent, severity and progression of this multisystem condition.

